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A Closed Loop Brain-machine 
Interface for Epilepsy Control 
Using Dorsal Column Electrical 
Stimulation
Miguel Pais-Vieira1,2,3,*, Amol P. Yadav1,4,*, Derek Moreira1, David Guggenmos1, 
Amílcar Santos1, Mikhail Lebedev4,5 & Miguel A. L. Nicolelis1,4,5,6,7
Although electrical neurostimulation has been proposed as an alternative treatment for drug-resistant 
cases of epilepsy, current procedures such as deep brain stimulation, vagus, and trigeminal nerve 
stimulation are effective only in a fraction of the patients. Here we demonstrate a closed loop brain-
machine interface that delivers electrical stimulation to the dorsal column (DCS) of the spinal cord to 
suppress epileptic seizures. Rats were implanted with cortical recording microelectrodes and spinal 
cord stimulating electrodes, and then injected with pentylenetetrazole to induce seizures. Seizures 
were detected in real time from cortical local field potentials, after which DCS was applied. This 
method decreased seizure episode frequency by 44% and seizure duration by 38%. We argue that the 
therapeutic effect of DCS is related to modulation of cortical theta waves, and propose that this closed-
loop interface has the potential to become an effective and semi-invasive treatment for refractory 
epilepsy and other neurological disorders.
Drug-resistant epilepsy constitutes about 22.1% of the total cases of epileptic patients1. Historically, these cases 
have been treated with surgery2, but more recently electrical neurostimulation has emerged as a potential alter-
native therapeutic approach3. Deep brain4, vagus5, and trigeminal6,7 nerve stimulation, a procedure pioneered in 
our laboratory, have been proposed over the past decade as new alternatives to treat refractory epilepsy. However, 
each of these three alternative therapies has its advantages and disadvantages. For example, deep brain stimula-
tion (DBS) has a success rate of 60% in patients with refractory epilepsy8, but requires extremely invasive brain 
surgery. Therefore, a smaller number of patients will be eligible for DBS when compared to the other alternative 
therapies9. Trigeminal nerve stimulation (TNS) is far less invasive than DBS, but has a success rate of only 30.2%6. 
Lastly, vagus nerve stimulation (VNS) is also less invasive than DBS, but its success rate is the lowest among all 
three therapies at 24–28% in randomized clinical trials10,11.
Electrical stimulation of the posterior funiculus, also known as the dorsal column, of the spinal cord is a 
semi-invasive method12 which we have demonstrated to be effective for Parkinson’s disease (PD) treatment in 
rodents13,14 and primates15, and others have shown to be effective in Parkinsonian patients16,17. Remarkably, the 
neurophysiological hallmark of Parkinson’s disease in animal models is defined by hypersynchronized neuronal 
activity in the beta band of local field potentials (LFPs)13,15. The LFP patterns observed during these periods of 
hypersynchronized neuronal activity in Parkinson’s disease resembled some of the patterns of hypersynchro-
nized neuronal activity previously reported in pentylenetetrazol (PTZ) injected rats18. This latter similarity and 
the fact that this neuronal hypersynchronization can be specifically disrupted by DCS13–15 led us to hypothesize 
that DCS could be used as an alternative treatment for chronic refractory epilepsy. Although a recent study has 
demonstrated that DCS improved seizure related activity in anesthetized rats injected with PTZ19, the full clinical 
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potential of DCS can only be truly addressed in awake animals with DCS being applied in a closed loop mode (i.e. 
triggered only when a seizure is detected by an alternative measurement, such as cortical neuronal recordings). 
While PTZ injection may not be the best model to represent the subset of patients with refractory epilepsy20, it has 
provided the most promising results of DCS as an alternative to current neurostimulation techniques19.
Here we developed a closed-loop brain-machine interface (BMI) that utilized chronic cortical implants to 
detect seizure activity in awake, freely moving PTZ-treated rats (Fig. 1A,B). This BMI also allowed DCS to be 
delivered using the method we previously developed to suppress Parkinson’s symptoms in rodents13. Overall, we 
observed that this closed-loop BMI substantially reduced the frequency and duration of seizure episodes.
Results
A total of 10 rats (six male and four female) were implanted with stimulation and recording electrodes. Several 
days after the animals recovered from this implantation surgery, they were injected with PTZ and the efficacy of 
our closed-loop BMI in suppressing seizure episodes and reducing their duration was examined in 30 experimen-
tal sessions. Cortical microelectrode implants were placed in the primary somatosensory cortex (S1) and used for 
local field potential recordings (LFPs). Dorsal column stimulation electrodes were placed at the level of vertebral 
T1-T2 segments)13,14 (Fig. 1C). Two types of experiments were conducted in these 10 animals.
Experiment 1: BMI-On versus BMI-Off. In the first experiment (6 male and 3 female rats; 23 experimen-
tal sessions), seizure parameters were measured in PTZ-treated rats either with or without DCS driven by the 
closed loop BMI (BMI-On and BMI-Off sessions, respectively). In BMI-On sessions, each time a seizure detec-
tion threshold was crossed (Fig. 1D), five trains of 200 electrical biphasic pulses (100–200 uAmp) were delivered 
at the frequency of 500 Hz to the dorsal column. In BMI-Off sessions, the recording and stimulation equipment 
were connected the same way, but no DCS was delivered to the animals.
Injection of PTZ induced characteristic spike and wave discharges (SWDs)21 that were very evident in cortical 
LFP recordings (Fig. 1D) and triggered body twitches as their main behavioral manifestation. SWD frequency 
Figure 1. Closed loop brain-machine interface setup. (A) Local Field Potentials recorded from primary 
somatosensory cortex are analyzed in real time. High amplitude signals trigger the microstimulator (Master8) 
which will deliver an electrical pattern to the dorsal columns (DCS). (B) Recording electrodes placement44. 
(C) Stimulating electrodes placement (resting in the epidural space between the vertebrae and the spinal cord). 
(D) Raw LFP recording with multiple crossings of pre-established threshold (red dashed lines). The yellow bars 
indicate DCS delivered whenever the threshold was crossed. Bottom: Spectrogram depicting a seizure episode.
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typically increased until a seizure episode occurred (Fig. 1D). Once a seizure was detected, our BMI delivered the 
DCS after each SWD with a 50 ms delay.
Comparison of the BMI-On and BMI-Off sessions showed that closed loop DCS affected multiple physi-
ological parameters (Fig. 2A–G). In particular, DCS reduced the overall number of seizure episodes by 44% 
(BMI-On: 0.05 ± 0.01 episodes/min; BMI-Off: 0.09 ± 0.02 episodes/min; Paired Samples test t = 2.816, df = 5; 
P = 0.0373; Fig. 2A) as well as the number of SWDs by 72% (BMI-On: 1.8 ± 0.3 SWD/min; Off: 6.5 ± 2.6 SWD/
min; Wilcoxon signed-rank test = 21; P = 0.0313). Additionally, DCS reduced seizure duration by 34.86% 
(BMI-On: 31.39 ± 2.4 secs; Off: 48.19 ± 3.5 secs; Min: 9 secs; Max: 136 secs; Mann-Whitney U = 551.5; P = 0.0012, 
Fig. 2B; Partial indicates episodes where the BMI failed to deliver DCS). No differences were found in seizure epi-
sode characteristics when rats, tested in the same conditions, were compared across consecutive sessions (paired 
Figure 2. DCS improves seizure related activity. (A) DCS reduced the frequency of seizure episodes. The only 
case where the frequency of seizures was not reduced (red line, Fig. 2A), corresponds to a session that ended 
earlier due to technical problems. Symbols X and + correspond each one to a rat with a single BMI-Off or -On 
session. (B) DCS reduced seizure duration. ‘Partial’ indicates seizures where the BMI was activated only during 
a fraction of the episode. (C,D) Examples of raw LFP signals and corresponding spectrogram for a BMI-Off 
and a BMI-On session. During BMI-Off sessions, pre-ictal activity (approximately 1600 seconds) presented a 
characteristic signature pattern (see text for details). (E) Detail of BMI-Off session presented in C (color code as 
above). (F,G) In BMI-Off sessions, the pre-ictal theta frequency signal was a good predictor of seizure duration, 
however during BMI-On sessions, DCS specifically disrupted this signal. Also, note that long seizures  
(≥ 60 secs) were mostly absent during BMI-On sessions.
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samples t-test; Duration: T = 0.3314, df = 4; P = 0.7570, n.s.; Frequency: T = 0.48, df = 4; P = 0.67, n.s,), suggest-
ing that the differences between BMI-On and –Off sessions were not due to repeated PTZ administration.
Further analysis of the distribution of seizure episode durations showed that DCS negatively skewed this 
distribution, meaning that long seizure episodes (longer than 60 s) became much less frequent (BMI-On: 
1/30 = 3.3% episodes; BMI-Off: 11/62 = 17.74% episodes; Fisher’s exact test: P = 0.048; compare Y axis values in 
Fig. 2 between F,G).
Frequency spectral analysis indicated that DCS specifically disrupted the LFP spectral pattern that preceded 
the onset of each seizure episode22 in PTZ treated rats. This LFP pattern consisted of an elevated theta band 
(~4 Hz to 8–10 Hz), which often appeared as a parabola22. These PTZ-related theta episodes, which usually 
lasted approximately 5–10 s (compare Fig. 2 panels C,D), occurred in a very narrow range of frequencies and 
occasionally appeared in higher harmonic frequencies (see arrow in Fig. 2C, also 2E). Thus, although pre-ictal 
activity very often included other bands, spectrogram changes associated with the period occurring immedi-
ately before the seizure episode most reliably appeared in the theta frequency. During BMI-On sessions, this 
PTZ-induced elevated theta band pattern was disrupted. This means that, after the delivery of DCS, the specific 
parabola pattern was no longer present even when this frequency band still presented a high potency signal. The 
main effect observed was an increase of LFP power in a wide theta range (4.5–8 Hz) (BMI-On: − 27.57 ± 1.4 dB; 
BMI-Off: − 33.01 ± 1.3 dB; t = 2.64, df = 90; P = 0.0098; also see right shift in X axis values in Fig. 2F,G). Lastly, 
DCS also induced longer periods with reduced pre-ictal theta band power (BMI-On: 2.81 ± 1.81 secs; BMI-Off: 
1.51 ± 0.13 secs; Mann-Whitney U = 306; P = 0.0038). Thus, DCS induced a reduction in the proportion of long 
seizure episodes, an increase in theta power and range (compare Long and Regular in Fig. 2F,G), and allowed for 
longer periods with low power in the theta band.
These findings suggest to us that the elimination of the theta pattern by DCS may have accounted for the 
mechanism that led to seizure reduction. In support of this theory, we observed that theta band power dur-
ing the pre-ictal period was a good predictor of longer seizure duration in BMI-Off sessions (F1,55 = 17.09; 
R2 = 0.23;P < 0.0001: see Fig. 2E,F). By contrast, during BMI-On sessions, theta band power was no longer corre-
lated to seizure duration (BMI-On: F1,28 = 0.32; R2 = 0.01;P = 0.579, n.s.; Fig. 2G).
Experiment 2: Mixed BMI on and off episodes within a session. To test how fast our BMI became effec-
tive in reducing PTZ induced seizures, we turned the BMI on and off periodically within the same experimental 
session. We called these experiments the mixed sessions (N = 7 rats, 4 male and 3 female in seven sessions; see 
Fig. 3A). Seizure episode durations now varied between 9 and 76 seconds. Under these conditions, we found that 
our closed-loop BMI still drastically reduced episode duration by 42.15% (BMI-On: 26.5 ± 2.1 secs; BMI-Off: 
45.81 ± 3.2 secs; Mann-Whitney U = 74; P < 0.0001; see Fig. 3B; Partial indicates episodes where the BMI failed 
to deliver DCS).
As in the case of the first experiment, pre-ictal theta band power was a good predictor of seizure duration 
in the mixed sessions when the BMI was off (F1,15 = 5.80; R2 = 0.28; P = 0.0293; Fig. 3C). Once again, when the 
BMI was on, the theta band power no longer correlated with seizure duration (BMI-On: F1,28 = 0.38; R2 = 0.01; 
P = 0.54, n.s.). Conspicuously, analysis of long seizure episodes (i.e. ≥ 60 seconds) now revealed that turning the 
BMI on in a fraction of the seizure episodes significantly reduced the number of these long seizures even when 
the BMI was off (BMI-On: 0/30 = 0% episodes; BMI-Off: 2/17 = 11.8%; Fisher’s exact test: P = 0.145, n.s.; also see 
Fig. 3C, compare Regular to Long). This finding suggested that, during the course of a PTZ session, the delivery 
of the DCS pattern during one seizure episode could, to some extent, affect the characteristics of the following 
episode13–15, even if no DCS was delivered at that particular episode. In other words, we found evidence for a 
long-lasting effect of DCS, similar to what we had reported before when we used DCS to treat rat and monkey 
models of Parkinson’s disease13–15.
To further test this possibility, we looked at the characteristics of the pre-ictal theta band signal, which in 
Experiment 1 was very different between BMI-On and BMI-Off sessions, during the mixed sessions. In this 
latter case we found that, not only was the pre-ictal theta band signal potency now similar between BMI-On and 
BMI-Off seizure episodes (BMI-On: 30.50 ± 1.5 dB; BMI-Off:27.25 ± 2.2 dB; paired samples t test t = 1.452,df = 6; 
P = 0.1968, n.s.), but that the theta band amplitude signals obtained during the BMI-Off episodes were now 
closer to those measured during BMI-On episodes (also compare values in X axis in Fig. 2F to values in Fig. 3C). 
Lastly, analysis of low power theta band durations (which in experiment 1 were smaller for BMI Off episodes), 
also revealed that these were now similar between BMI-On and BMI-Off episodes (BMI-On: 2.31 ± 0.34 secs; 
BMI-Off: 2.44 ± 0.38 secs; Man-Whitney U = 163.5, P = 0.7084, n.s.). Therefore, these results suggest that, in this 
experiment, BMI-Off episodes where, to some extent, affected by DCS delivered during the BMI-On episodes.
DCS is effective in both male and female rats. To identify possible gender specific differences in our 
results23, we further pooled male or female rats from both experiments and compared the main findings of this 
study according to animal gender. The use of DCS reduced the overall duration of seizure episodes in both male 
(t-test with Welch’s correction, t = 4.665, df = 59, P < 0.0001) and female rats (t-test with Welch’s correction, 
t = 3.563, df = 59, P = 0.0007). Additionally, the pre-ictal theta band signal was predictive of seizure episodes 
in both male (BMI-Off: F1,42 = 13.37; R2 = 0.24;P = 0.0007) and female rats (BMI-Off: F1,33 = 4.357; R2 = 0.12; 
P = 0.0447) when DCS was Off, but not when it was On (BMI-On Male: F1,29 = 0.42; R2 = 0.01;P = 0.52, n.s.; 
BMI-On Female: F1,28 = 0.30; R2 = 0.01;P = 0.59, n.s.).
Discussion
We demonstrated here the efficacy of a closed-loop BMI that triggered DCS in response to pre-seizure and sei-
zure patterns in LFP activity in PTZ-treated rats. Overall, we observed that our BMI quite effectively reduced the 
number of seizure episodes, and their duration, while also changing the overall pattern of LFP activity associated 
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with the pre-ictal phase of PTZ-triggered seizures. Therefore, we propose that the main anti-seizure effect of DCS 
is obtained via the reduction in the pre-ictal theta band activity, a good predictor of seizure duration. Lastly, we 
found that our BMI was effective in both male and female rats, even though our experiments were not controlled 
for the estrous cycle23.
Previous studies have shown increases as well as decreases in epileptic related activity after treatment with 
DCS19,24. Here, we have specifically used DCS in response to a change in LFPs signal and consistently observed 
improvement in multiple physiological parameters. We attribute the differences between our findings and previ-
ous results to the fact that we delivered DCS only in response to LFP changes instead of stimulating indiscrimi-
nately24. Another important factor is that we only employed high frequency DCS in the present study, since we 
and others have observed (D.G.: personal observation) increased seizure activity when low frequency DCS was 
delivered24. Using transcranial electrical stimulation in a different model, Berenyi et al. have developed a closed 
loop BMI for epilepsy21. While that study was able to achieve reductions in seizure related activity somewhat 
higher than the ones achieved here, it is important to note that they used a different chemical agent. Future studies 
comparing different BMI approaches and epilepsy models will help identifying pros and cons, as well as efficacy, 
of each technique. At this point it is important to recall that the PTZ model – as used here - may not be the best 
animal model to represent the subset of patients with refractory epilepsy20. Therefore, the effects of our closed 
loop BMI will have to be further tested in other animal models of epilepsy.
It could be argued that the differences found between BMI-On and -Off seizure episodes reported here could 
be the result of differences originating from repeated PTZ administration. Although repeated administration of 
PTZ is often used as a model for chronic seizures (see Erkeç and Arihan 2015 for a review)25 our results cannot 
be explained by such effect alone. First, in experiment 1, not only BMI-On and -Off sessions were typically alter-
nated, but some rats started with BMI-Off sessions while others started with BMI-On sessions. Second, there was 
no difference in seizure episodes (duration and frequency) in rats tested in the same conditions in consecutive 
sessions. Third, most PTZ kindling protocols involve more than 10 doses of PTZ25–27 or intervals of more than 
20 days between the series of PTZ injections28. Lastly, results from experiment 2 (where the BMI was turned On 
and Off within the same session) further controlled for the possibility of differences in BMI-On and -Off sessions 
being the result of PTZ-induced kindling alone.
This study also reports, for the first time, that the pre-ictal theta band signal can be used as good predictor 
for seizure episode duration in PTZ-treated rats. It is not yet clear why this signal is related to the duration of the 
Figure 3. Intermittent delivery of DCS improves seizure related activity. (A) Example of session where the 
BMI was turned On or Off in successive seizure episodes. (B) DCS reduced seizure duration. Partial indicates 
seizure episodes where DCS was delivered only in a fraction of the episode. (C) In BMI-Off episodes, the pre-
ictal theta frequency signal was a good predictor of seizure duration. During BMI-On episodes, DCS specifically 
disrupted this signal. Also, note that long seizures (≥ 60 secs) were absent during BMI-On episodes and during 
BMI-Off episodes as well (see text for details).
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seizure episodes, but a possible explanation involves a mechanism where a state of seizure derives from an abnor-
mal transition between brain states resulting from an imbalance between corticofugal inhibition and thalam-
ocortical excitation. In healthy rodents, strong increases in theta band signal, with partial increases in other 
frequencies, are also present during whisker twitching29,30, a non-pathological seizure-like state controlled by S1 
that is characterized by general immobility coupled with improved ability to detect incoming tactile stimuli. From 
this cortically controlled state, neural activity does not usually evolve to seizure episodes, but rather transitions to 
a state of quiet waking where the animal is either immobile or engaged in stereotyped behaviors31.
In a rat model of cortical injury generated epilepsy, an initial stimulus from the injured area to the thalamus 
will make the thalamocortical loop transition to a hypersynchronization state characterized by seizures32. This 
state is maintained by the thalamus and can be reversed by optogenetic thalamic stimulation32. Together, these 
findings suggest that many of the differences found in theta power in this and previous studies could be the result 
of this critical balance in the thalamocortical loop where S1 corticofugal inhibition33 maintains theta oscillations 
within a normal range (i.e. whisker twitching), but that otherwise, if theta oscillations become mostly dependent 
on a hyper excitable thalamus32,34, this state will then transition to a state of hypersynchronized seizure activity. 
Note that such a mechanism could additionally explain the differences found in previous DCS studies. Thus, if 
theta band activity critically reflects a balance between thalamic and cortical activity, electrical stimulation to 
the lemniscal pathway could result in thalamic increased excitability or, if sufficiently strong, it could in addition 
stimulate S1 and increase cortico-thalamic inhibition33. The differences in seizure related activity found when 
DCS was applied with low or high frequencies can be partially explained within this framework. Low frequency 
DCS would increase seizure activity24 because it should affect mostly thalamocortical synapses, while increasing 
stimulation frequency should be able to increase both the thalamus and S1 (Supplementary Figure S1), therefore 
activating the corticofugal synapses and improving seizure related activity (ref. 19 and here). Lastly, this critical 
balance between S1 inhibition and thalamic excitation could also explain the predictive power of the pre-ictal 
signal. The observation that S1 controls the state of whisker twitching (which is characterized by high potency 
theta oscillations) suggests that the bimodal distribution of the predictive pre-ictal theta signal found here may 
actually correspond to two different brain states resulting from the initial conditions imposed by the pre-ictal 
theta signal (one prone to long seizures and another one prone to short seizures). In this scenario, a theta signal 
smaller than − 45 dB in S1 (Fig. 2F) after the injection of PTZ would constitute the critical potency required to 
disrupt the balance in the thalamocortical loop, transitioning to a state of long seizures, while a theta signal larger 
than − 45 dB, while still disrupting the balance in the thalamocortical loop, would promote transition to a state 
where short seizures occur. It is important to note however that DCS activates multiple regions, making it unlikely 
that the proposed mechanism would be the only source for the brain state transitions described. Future studies 
involving recordings and stimulation across the thalamocortical loop will allow dissecting to what extent DCS 
affects this theta signal in each structure as well as its significance in different thalamocortical states.
Electrical neural stimulation has been used as an alternative to surgery for intractable epilepsy cases, primarily 
through deep brain stimulation, vagal nerve stimulation, and trigeminal nerve stimulation. Deep brain stimu-
lation has presented an efficacy of up to 68% responders after 5 years35 but is extremely invasive and cannot be 
performed in many patients. Meanwhile, vagal and trigeminal nerve stimulation procedures, have demonstrated 
relatively low efficacy, with 49%36 and 50%37 respectively, and may have more side effects38 than deep brain stim-
ulation. Thus, on one side, deep brain stimulation has achieved very good seizure reduction, but is extremely 
invasive and expensive, making it a solution for only a small fraction of the patients in need. On the other side, 
more peripheral stimulation procedures, which are much less expensive and invasive, have a much lower efficacy 
rate and are associated with increased side effects. Finally, DCS seems to rest in the middle ground between these 
other electrical neurostimulation alternatives, since it’s less invasive than deep brain stimulation and few side 
effects have been reported when DCS is used for other diseases39. Translating our findings into human patients 
will allow comparison of the efficacy rate between DCS and these other alternatives.
Previously we have shown that DCS ameliorates symptoms of Parkinson’s disease by desynchronizing patho-
logical low frequency corticostriatal oscillations, therefore creating a brain state permissible for the initiation 
of locomotion in severely dopamine depleted rodents and non-human primates13,15. More specifically, high 
frequency DCS inhibited oscillatory neuronal activity synchronized at the beta frequency in the basal ganglia 
through activation of various structures along the dorsal column medial lemniscal pathway15. Our present PTZ 
results are in line with these previous Parkinson’s disease studies, by suggesting that DCS is responsible for the 
desynchronization of pathological synchronous activity characteristic of the PTZ model of epilepsy. In fact, this 
observation can be generalized to other disorders, since we and others have demonstrated that pathological 
synchronous activity seems to be the hallmark of pathological brain states recorded from multiple models of 
neurological and neuropsychiatric disorders such as Parkinson’s disease13–15, epilepsy (here and ref. 19), bipolar 
disorder40, and schizophrenia41. Therefore, based on this cumulative body of evidence showing abnormal timing 
in brain circuitry, we propose that the aforementioned diseases can all be classified within a broad spectrum of 
pathological timing brain states (i.e. hyper- or hyposynchronized), that resemble the basic neurophysiological 
hallmarks of epilepsy. While these diseases share excessive synchronization as a common feature, they differ in 
the type of neural circuits involved in each case42. A testable prediction of this hypothesis would be that any type 
of nerve stimulation capable of significantly altering the balance between regions responsible for these synchro-
nizations, should also be able to induce at least a partial relief of symptoms in these disorders42,43.
In conclusion, we propose that DCS should be tested in other rodent and primate models of chronic epilepsy 
to measure its efficacy in controlling these pathological brain states over longer periods of time. These studies 
would be essential to determine the true potential of DCS as a non-pharmacologic alternative therapy for use in 
humans suffering from chronic, untreatable epilepsy.
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Methods
All animal procedures were performed in accordance with the National Research Council’s Guide for the Care 
and Use of Laboratory Animals and were approved by the Duke University Institutional Animal Care and Use 
Committee. Long Evans male and female rats weighing between 250–400 g were used in all experiments.
Surgery for microelectrode array implantation. Animals went through two different surgeries: one to 
implant recording electrodes and the other to implant the stimulation electrodes. Recording electrodes: Fixed or 
movable microelectrode bundles or arrays of electrodes were implanted in the S1 of rats and additional regions 
(for the present study we did not evaluate the activity in other regions). Anesthesia was induced with 5% halo-
thane, and maintained with ketamine (100 mg/kg), xylazine (10 mg/kg) and atropine (0.05 ml). Craniotomies 
for S1 recordings were made and arrays lowered at the following stereotaxic coordinates: [(AP) − 3.5 mm, (ML), 
− 5.5 mm (DV) − 1.5 mm]44. Stimulation electrodes for spinal stimulation were also implanted under anesthesia 
as described above. Postoperative weight was monitored daily. The implantation procedure was performed as 
previously described14. Specifically, stimulation electrodes were inserted in the epidural space under thoracic 
vertebra T2 and, to prevent electrode migration, were tied to it with surgical suture.
Electrophysiological recordings. A Multineuronal Acquisition Processor (64 channels, Plexon Inc, 
Dallas, TX) was used to record neuronal spikes, as previously described45. Briefly, neural signals were recorded 
differentially, amplified (20,000–32,000X), filtered (filtering band between 400 Hz and 5 kHz), and digitized at 
40 kHz. Local field potentials (LFPs) were acquired by band-pass filtering the raw signal (0.3–400.0 Hz), pream-
plified (1,000), and digitized at 1,000 Hz using a digital acquisition card (National Instruments, Austin, TX) and 
a multineuronal acquisition processor (Plexon).
Pentylenetetrazole administration. Each recording session, independently of the experiment, was per-
formed on a different day. Both male and female rats were tested under the exact same conditions. PTZ (SIGMA 
Aldrich) administration was prepared by dilution of 100 mg/kg of PTZ in 1 ml saline. This was then administered 
IP under isofluorane anesthesia. As BMI sessions were preceded by an initial baseline recording period, rats 
injected with the PTZ could be immediately brought to the recording room with a delay of no more than 5 min-
utes. BMI sessions started approximately 5–10 minutes after the administration of PTZ. The recording sessions 
(in both experiments) lasted 60 minutes. In preliminary experiments we observed that PTZ effects were less var-
iable within the first 60–90 minutes.
Data analysis. Neuronal data obtained from a total of 30 recording sessions was processed and analyzed 
using NeuroExplorer (version 3.266; NEX Technologies, Madison, AL) and custom scripts written in Matlab 
(12.0; Mathworks, Natick, MA). A seizure episode was defined as a period where observable muscle spasms and 
high amplitude oscillations in raw LFP trace, were accompanied by increased power across multiple frequency 
bands. Seizure episodes were initially identified during the session using both behavior and raw LFP traces as 
indicators, and later confirmed through detailed reanalysis of raw LFP traces and spectrograms. Comparison 
of seizure and SWD frequencies (calculated in seizure episodes or SWD events per minute) was made using a 
paired samples t test or Wilcoxon signed ranks test. When an animal had more than one BMI-On or BMI-Off 
session, a single value resulting from the mean of the sessions was used for comparison. Seizure duration was 
compared using the Mann-Whitney test. Analysis of the overall distribution of seizure durations indicated a 
bimodal distribution. Accordingly, seizure episodes were analyzed as Long (≥ 60 secs) or Regular (< 60 secs). Then 
the proportion of Regular and Long seizure episodes was calculated for BMI-On and BMI-Off episodes. Lastly, 
the proportion of Regular and Long seizure episodes was compared using Fisher’s exact test. These calculations 
were performed separately for each experiment. For comparison of pre-ictal theta band spectrogram power we 
used values from 4.5–8 Hz frequencies in the 5 seconds before the timestamp that was identified as the start of 
the seizure episode. Theta power was calculated from the original signal processed in Neuroexplorer, followed by 
processing with custom scripts written in Matlab. Values were normalized with the Log of power spectral density 
(dB) and initially analyzed in bins of 100 ms. Calculation of theta power for correlation was made using a single 
5 second bin (the 5 seconds immediately before seizure onset) for theta frequency that was then correlated to sei-
zure episode duration. For ease of presentation, spectrograms are presented in bins of 100 ms and smoothed with 
a Gaussian filter of 300 ms. Statistical comparison of pre-ictal theta band power was made using an independent 
(Experiment 1) or paired (Experiment 2) samples t test. Pearson correlation was calculated using seizure episode 
duration and the pre-ictal theta power. The duration of theta band potency decrease was compared using data 
from the spectrogram of the whole session initially processed in 1 second bins in Neuroexplorer. A Zscore was 
calculated for theta band frequency for each bin across the session, and then periods of 5 seconds before the onset 
of each seizure episode were analyzed. As increased theta band Zscores were present almost exclusively during 
seizure episodes or spike-and-wave discharges, we analyzed instead periods where Zscores decreased (i.e. indicat-
ing a low potency theta band signal). Decreases in theta potency were considered here as a Zscore equal or below 
1.0 standard deviation. The duration of each response was then considered as the number of consecutive bins 
where the potency of the signal corresponded to this criterion. Lastly, duration of low theta power responses was 
compared between BMI-On and BMI-Off episodes in each separate experiment, using the Mann-Whitney U test.
Brain-machine interface based on Dorsal Column Stimulation. Our brain-machine interface used 
Dorsal Column Stimulation (DCS) cues that were generated by an electrical microstimulator (Master 8. AMPI, 
Jerusalem, Israel) controlled by a custom Matlab script (Natick, USA) receiving information from a Plexon sys-
tem over the internet. This real-time neural analysis and stimulation system has been previously described for a 
different purpose46,47. Here, we have pre-determined for each rat, a threshold in raw LFP traces that was typically 
crossed only in the presence of LFP epileptic activity (i.e. spike and wave discharges or seizure episodes). Upon 
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detection of such threshold crossing, a pattern of 200 (bipolar, biphasic, charge balanced; 200 μ sec) pulses at 
500 Hz was delivered to the dorsal column of the spinal cord at the level of T1-T2 segments. Current intensity var-
ied from 100–200 μ A. Seizure episodes where DCS failed to stimulate for at least 75% of the episode duration were 
considered as ‘Partial’ stimulation and were excluded from final analysis. These included a total of 6/53 = 11.32% 
episodes in Experiments 1 and 2.
In Experiment 1 rats were typically tested in BMI-On and BMI-Off sessions on alternate days. Similarly, in 
Experiment 2, rats seizure episodes with BMI-On were alternated with BMI-Off episodes. Changes to these 
pre-established conditions were made when technical problems occurred (e.g. incomplete session, cable discon-
necting, noise, inadequate threshold etc.).
References
1. Picot, M. C., Baldy-Moulinier, M., Daures, J. P., Dujols, P. & Crespel, A. The prevalence of epilepsy and pharmacoresistant epilepsy 
in adults: a population-based study in a Western European country. Epilepsia 49, 1230–1238, doi: 10.1111/j.1528-1167.2008.01579.x 
(2008).
2. Horsley, V. B-surgery. Br. Med. J. 2, 670–675 (1886).
3. Mogul, D. J. & van Drongelen, W. Electrical control of epilepsy. Annu. Rev. Biomed. Eng. 16, 483–504, doi: 10.1146/annurev-
bioeng-071813-104720 (2014).
4. Fisher, R. et al. Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51, 899–908, 
doi: 10.1111/j.1528-1167.2010.02536.x (2010).
5. De Herdt, V. et al. Vagus nerve stimulation for refractory epilepsy: a Belgian multicenter study. Eur. J. Paediatr. Neurol. 11, 261–269, 
doi: 10.1016/j.ejpn.2007.01.008 (2007).
6. DeGiorgio, C. M. et al. Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy. Neurology 80, 
786–791, doi: 10.1212/WNL.0b013e318285c11a (2013).
7. Fanselow, E. E., Reid, A. P. & Nicolelis, M. A. Reduction of pentylenetetrazole-induced seizure activity in awake rats by seizure-
triggered trigeminal nerve stimulation. J. Neurosci. 20, 8160–8168 (2000).
8. Bergey, G. K. et al. Long-term treatment with responsive brain stimulation in adults with refractory partial seizures. Neurology 84, 
810–817, doi: 10.1212/WNL.0000000000001280 (2015).
9. Morgante, L. et al. How many parkinsonian patients are suitable candidates for deep brain stimulation of subthalamic nucleus? 
Results of a questionnaire. Parkinsonism Relat. Disord. 13, 528–531, doi: 10.1016/j.parkreldis.2006.12.013 (2007).
10. Morrell, M. J. & Group, R. N. S. S. i. E. S. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. 
Neurology 77, 1295–1304, doi: 10.1212/WNL.0b013e3182302056 (2011).
11. Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically 
intractable seizures. Neurology 45, 224–230 (1995).
12. Shealy, C. N., Mortimer, J. T. & Reswick, J. B. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical 
report. Anesth. Analg. 46, 489–491 (1967).
13. Fuentes, R., Petersson, P., Siesser, W. B., Caron, M. G. & Nicolelis, M. A. Spinal cord stimulation restores locomotion in animal 
models of Parkinson’s disease. Science 323, 1578–1582, doi: 10.1126/science.1164901 (2009).
14. Yadav, A. P. et al. Chronic spinal cord electrical stimulation protects against 6-hydroxydopamine lesions. Sci. Rep. 4, 3839, doi: 
10.1038/srep03839 (2014).
15. Santana, M. B. et al. Spinal cord stimulation alleviates motor deficits in a primate model of Parkinson disease. Neuron 84, 716–722, 
doi: 10.1016/j.neuron.2014.08.061 (2014).
16. Agari, T. & Date, I. Spinal cord stimulation for the treatment of abnormal posture and gait disorder in patients with Parkinson’s 
disease. Neurol. Med. Chir. (Tokyo). 52, 470–474 (2012).
17. Fenelon, G. et al. Spinal cord stimulation for chronic pain improved motor function in a patient with Parkinson’s disease. 
Parkinsonism Relat. Disord. 18, 213–214, doi: 10.1016/j.parkreldis.2011.07.015 (2012).
18. Zhang, T. et al. Pre-seizure state identified by diffuse optical tomography. Sci. Rep. 4, 3798, doi: 10.1038/srep03798 (2014).
19. Jiao, J., Jensen, W., Harreby, K. R. & Sevcencu, C. The Effect of Spinal Cord Stimulation on Epileptic Seizures. Neuromodulation 19, 
154–160, doi: 10.1111/ner.12362 (2016).
20. Loscher, W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new 
antiepileptic drugs. Seizure 20, 359–368, doi: 10.1016/j.seizure.2011.01.003 (2011).
21. Berenyi, A., Belluscio, M., Mao, D. & Buzsaki, G. Closed-loop control of epilepsy by transcranial electrical stimulation. Science 337, 
735–737, doi: 10.1126/science.1223154 (2012).
22. Schevon, C. A. et al. Evidence of an inhibitory restraint of seizure activity in humans. Nat.Commun. 3, 1060, doi: 10.1038/
ncomms2056 (2012).
23. Christensen, J., Kjeldsen, M. J., Andersen, H., Friis, M. L. & Sidenius, P. Gender differences in epilepsy. Epilepsia 46, 956–960, doi: 
10.1111/j.1528-1167.2005.51204.x (2005).
24. Harreby, K. R., Sevcencu, C. & Struijk, J. J. The effect of spinal cord stimulation on seizure susceptibility in rats. Neuromodulation 14, 
111–116; discussion 116, doi: 10.1111/j.1525-1403.2010.00320.x (2011).
25. Erkec, O. E. & Arihan, O. Pentylenetetrazole Kindling Epilepsy Model. Epilepsi 21, 6–12, doi: 10.5505/epilepsi.2015.08108 (2015).
26. Corda, M. G. et al. Pentylenetetrazol-induced kindling in rats: effect of GABA function inhibitors. Pharmacol. Biochem. Behav. 40, 
329–333 (1991).
27. Ilhan, A., Iraz, M., Kamisli, S. & Yigitoglu, R. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 
761) in mice. Prog Neuropsychopharmacol Biol. Psychiatry 30, 1504–1510, doi: 10.1016/j.pnpbp.2006.05.013 (2006).
28. Davoudi, M., Shojaei, A., Palizvan, M. R., Javan, M. & Mirnajafi-Zadeh, J. Comparison between standard protocol and a novel 
window protocol for induction of pentylenetetrazol kindled seizures in the rat. Epilepsy Res 106, 54–63, doi: 10.1016/j.
eplepsyres.2013.03.016 (2013).
29. Fanselow, E. E., Sameshima, K., Baccala, L. A. & Nicolelis, M. A. Thalamic bursting in rats during different awake behavioral states. 
Proc. Natl. Acad. Sci. USA 98, 15330–15335, doi: 10.1073/pnas.261273898 (2001).
30. Nicolelis, M. A., Baccala, L. A., Lin, R. C. & Chapin, J. K. Sensorimotor encoding by synchronous neural ensemble activity at 
multiple levels of the somatosensory system. Science 268, 1353–1358 (1995).
31. Gervasoni, D. et al. Global forebrain dynamics predict rat behavioral states and their transitions. J. Neurosci. 24, 11137–11147, doi: 
10.1523/JNEUROSCI.3524-04.2004 (2004).
32. Paz, J. T. et al. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat. Neurosci. 16, 
64–70, doi: 10.1038/nn.3269 (2013).
33. Schlaier, J. R. et al. Effects of spinal cord stimulation on cortical excitability in patients with chronic neuropathic pain: a pilot study. 
Eur. J. Pain 11, 863–868, doi: 10.1016/j.ejpain.2007.01.004 (2007).
34. Fanselow, E. E. & Nicolelis, M. A. Behavioral modulation of tactile responses in the rat somatosensory system. J. Neurosci. 19, 
7603–7616 (1999).
www.nature.com/scientificreports/
9Scientific RepoRts | 6:32814 | DOI: 10.1038/srep32814
35. Salanova, V. et al. Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy. Neurology 84, 1017–1025, 
doi: 10.1212/WNL.0000000000001334 (2015).
36. Englot, D. J., Rolston, J. D., Wright, C. W., Hassnain, K. H. & Chang, E. F. Rates and Predictors of Seizure Freedom With Vagus Nerve 
Stimulation for Intractable Epilepsy. Neurosurgery, doi: 10.1227/NEU.0000000000001165 (2015).
37. Zare, M. et al. Trigeminal nerve stimulation: A new way of treatment of refractory seizures. Adv. Biomed. Res. 3, 81, doi: 
10.4103/2277-9175.127994 (2014).
38. Kahlow, H. & Olivecrona, M. Complications of vagal nerve stimulation for drug-resistant epilepsy: a single center longitudinal study 
of 143 patients. Seizure 22, 827–833, doi: 10.1016/j.seizure.2013.06.011 (2013).
39. Hayek, S. M., Veizi, E. & Hanes, M. Treatment-Limiting Complications of Percutaneous Spinal Cord Stimulator Implants: A Review 
of Eight Years of Experience From an Academic Center Database. Neuromodulation 18, 603–608; discussion 608-609, doi: 10.1111/
ner.12312 (2015).
40. Dzirasa, K. et al. Impaired limbic gamma oscillatory synchrony during anxiety-related behavior in a genetic mouse model of bipolar 
mania. J. Neurosci. 31, 6449–6456, doi: 10.1523/JNEUROSCI.6144-10.2011 (2011).
41. Dzirasa, K. et al. Dopaminergic control of sleep-wake states. J. Neurosci. 26, 10577–10589, doi: 10.1523/JNEUROSCI.1767-06.2006 
(2006).
42. Cicurel, R. & Nicolelis, M. A. L. The relativistic brain: how it works and why it cannot by simulated by a Turing machine 1.1 edn, ISBN: 
1511617020 (Kios Press, 2015).
43. Nicolelis, M. A. L. Beyond boundaries: the new neuroscience of connecting brains with machines-and how it will change our lives 1st 
edn, (Times Books/Henry Holt and Co., 2011).
44. Paxinos, G. & Watson, C. The rat brain in stereotaxic coordinates. 4th edn, (Academic Press, 1998).
45. Nicolelis, M. A. L. Methods for neural ensemble recordings. 2nd edn, (CRC Press, 2008).
46. Pais-Vieira, M., Chiuffa, G., Lebedev, M., Yadav, A. & Nicolelis, M. A. Building an organic computing device with multiple 
interconnected brains. Sci. Rep. 5, 11869, doi: 10.1038/srep11869 (2015).
47. Pais-Vieira, M., Lebedev, M., Kunicki, C., Wang, J. & Nicolelis, M. A. A brain-to-brain interface for real-time sharing of sensorimotor 
information. Sci. Rep. 3, 1319, doi: 10.1038/srep01319 (2013).
Acknowledgements
We are grateful for the assistance from Jim Meloy for the design and production of the multielectrode arrays as 
well as setup development and maintenance, Laura Oliveira, Terry Jones, and Susan Halkiotis for administrative 
assistance and preparation of the manuscript. This work was funded by a grant from The Hartwell Foundation.
Author Contributions
M.P.-V., A.P.Y., M.L. and M.A.L.N. designed the experiments; M.P-V., A.P.Y., D.M., A.S. and D.G. performed 
the experiments; M.P-V., A.P.Y. and M.A.L.N. analyzed the data; M.P-V., A.P.Y., M.L. and M.A.L.N. wrote the 
manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Pais-Vieira, M. et al. A Closed Loop Brain-Machine Interface For Epilepsy Control 
Using Dorsal Column Electrical Stimulation. Sci. Rep. 6, 32814; doi: 10.1038/srep32814 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2016
